2019
Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders
Yilmaz A, Fuchs D, Price RW, Spudich S, Blennow K, Zetterberg H, Gisslén M. Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders. Current HIV/AIDS Reports 2019, 16: 76-81. PMID: 30649659, PMCID: PMC6420419, DOI: 10.1007/s11904-019-00420-1.Peer-Reviewed Original ResearchConceptsCSF neurograninCerebrospinal fluidProinflammatory cytokines IL-1βGroup of HIVLewy body dementiaCerebrospinal fluid concentrationsCytokines IL-1βLevels of neurograninNeurogranin concentrationsNeuro-HIVHIV neuropathogenesisSynaptic injuryHIV infectionIL-1βNeurocognitive disordersFrontal cortexParkinson's diseaseUninfected controlsReviewThe aimAlzheimer's diseaseNeurological disordersFrontotemporal dementiaNeurodegenerative disordersFluid concentrationsHIV
2008
HIV/AIDS of the Central Nervous System
Spudich S. HIV/AIDS of the Central Nervous System. 2008, 430-445. DOI: 10.1016/b978-012373960-5.00019-8.Peer-Reviewed Original ResearchNeurological disordersMajority of HIVPublic health burdenDisease-specific therapiesCentral nervous systemHIV/AIDSAntiretroviral treatmentOpportunistic infectionsPeripheral nervesVascular disordersSpinal cordHealth burdenHIV-1Nervous systemImportant causeNeurological diseasesNutritional diseasesDisordersHIVInfectionAIDSDiseaseDisease epidemicsMorbidityNerve